1 Market Overview

1.1 Overactive Bladder Medication Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Overactive Bladder Medication Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Anticholinergics

1.2.3 Mirabegron

1.2.4 Botox

1.3 Market Analysis by Application

1.3.1 Overview: Global Overactive Bladder Medication Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Idiopathic Overactive Bladder

1.3.3 Neurogenic Overactive Bladder

1.4 Global Overactive Bladder Medication Market Size & Forecast

1.4.1 Global Overactive Bladder Medication Sales in Value (2016-2026))

1.4.2 Global Overactive Bladder Medication Sales in Volume (2016-2026)

1.4.3 Global Overactive Bladder Medication Price by Type (2016-2026) & (USD/Unit)

1.5 Global Overactive Bladder Medication Production Capacity Analysis

1.5.1 Global Overactive Bladder Medication Total Production Capacity (2016-2026)

1.5.2 Global Overactive Bladder Medication Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Overactive Bladder Medication Market Drivers

1.6.2 Overactive Bladder Medication Market Restraints

1.6.3 Overactive Bladder Medication Trends Analysis

2 Manufacturers Profiles

2.1 KYORIN Pharmaceutical

2.1.1 KYORIN Pharmaceutical Details

2.1.2 KYORIN Pharmaceutical Major Business

2.1.3 KYORIN Pharmaceutical Overactive Bladder Medication Product and Services

2.1.4 KYORIN Pharmaceutical Overactive Bladder Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Astellas Pharma

2.2.1 Astellas Pharma Details

2.2.2 Astellas Pharma Major Business

2.2.3 Astellas Pharma Overactive Bladder Medication Product and Services

2.2.4 Astellas Pharma Overactive Bladder Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Johnson & Johnson

2.3.1 Johnson & Johnson Details

2.3.2 Johnson & Johnson Major Business

2.3.3 Johnson & Johnson Overactive Bladder Medication Product and Services

2.3.4 Johnson & Johnson Overactive Bladder Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Pfizer

2.4.1 Pfizer Details

2.4.2 Pfizer Major Business

2.4.3 Pfizer Overactive Bladder Medication Product and Services

2.4.4 Pfizer Overactive Bladder Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Allergan

2.5.1 Allergan Details

2.5.2 Allergan Major Business

2.5.3 Allergan Overactive Bladder Medication Product and Services

2.5.4 Allergan Overactive Bladder Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Overactive Bladder Medication Sales by Manufacturer

3.1 Global Overactive Bladder Medication Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Overactive Bladder Medication Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Overactive Bladder Medication

3.4 Market Concentration Rate

3.4.1 Top 3 Overactive Bladder Medication Manufacturer Market Share

3.4.2 Top 6 Overactive Bladder Medication Manufacturer Market Share

3.5 Global Overactive Bladder Medication Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Overactive Bladder Medication Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Overactive Bladder Medication Market Size by Region

4.1.1 Global Overactive Bladder Medication Sales in Volume by Region (2016-2026)

4.1.2 Global Overactive Bladder Medication Revenue by Region (2016-2026)

4.2 North America Overactive Bladder Medication Revenue (2016-2026)

4.3 Europe Overactive Bladder Medication Revenue (2016-2026)

4.4 Asia-Pacific Overactive Bladder Medication Revenue (2016-2026)

4.5 South America Overactive Bladder Medication Revenue (2016-2026)

4.6 Middle East and Africa Overactive Bladder Medication Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Overactive Bladder Medication Sales in Volume by Type (2016-2026)

5.2 Global Overactive Bladder Medication Revenue by Type (2016-2026)

5.3 Global Overactive Bladder Medication Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Overactive Bladder Medication Sales in Volume by Application (2016-2026)

6.2 Global Overactive Bladder Medication Revenue by Application (2016-2026)

6.3 Global Overactive Bladder Medication Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Overactive Bladder Medication Sales by Type (2016-2026)

7.2 North America Overactive Bladder Medication Sales by Application (2016-2026)

7.3 North America Overactive Bladder Medication Market Size by Country

7.3.1 North America Overactive Bladder Medication Sales in Volume by Country (2016-2026)

7.3.2 North America Overactive Bladder Medication Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Overactive Bladder Medication Sales by Type (2016-2026)

8.2 Europe Overactive Bladder Medication Sales by Application (2016-2026)

8.3 Europe Overactive Bladder Medication Market Size by Country

8.3.1 Europe Overactive Bladder Medication Sales in Volume by Country (2016-2026)

8.3.2 Europe Overactive Bladder Medication Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Overactive Bladder Medication Sales by Type (2016-2026)

9.2 Asia-Pacific Overactive Bladder Medication Sales by Application (2016-2026)

9.3 Asia-Pacific Overactive Bladder Medication Market Size by Region

9.3.1 Asia-Pacific Overactive Bladder Medication Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Overactive Bladder Medication Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Overactive Bladder Medication Sales by Type (2016-2026)

10.2 South America Overactive Bladder Medication Sales by Application (2016-2026)

10.3 South America Overactive Bladder Medication Market Size by Country

10.3.1 South America Overactive Bladder Medication Sales in Volume by Country (2016-2026)

10.3.2 South America Overactive Bladder Medication Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Overactive Bladder Medication Sales by Type (2016-2026)

11.2 Middle East & Africa Overactive Bladder Medication Sales by Application (2016-2026)

11.3 Middle East & Africa Overactive Bladder Medication Market Size by Country

11.3.1 Middle East & Africa Overactive Bladder Medication Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Overactive Bladder Medication Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Overactive Bladder Medication Typical Distributors

12.3 Overactive Bladder Medication Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Overactive Bladder Medication Revenue by Type, (USD Million), 2021-2026

Table 2. Global Overactive Bladder Medication Revenue by Application, (USD Million), 2021-2026

Table 3. KYORIN Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 4. KYORIN Pharmaceutical Major Business

Table 5. KYORIN Pharmaceutical Overactive Bladder Medication Product and Services

Table 6. KYORIN Pharmaceutical Overactive Bladder Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Astellas Pharma Basic Information, Manufacturing Base and Competitors

Table 8. Astellas Pharma Major Business

Table 9. Astellas Pharma Overactive Bladder Medication Product and Services

Table 10. Astellas Pharma Overactive Bladder Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table 12. Johnson & Johnson Major Business

Table 13. Johnson & Johnson Overactive Bladder Medication Product and Services

Table 14. Johnson & Johnson Overactive Bladder Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Pfizer Basic Information, Manufacturing Base and Competitors

Table 16. Pfizer Major Business

Table 17. Pfizer Overactive Bladder Medication Product and Services

Table 18. Pfizer Overactive Bladder Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Allergan Basic Information, Manufacturing Base and Competitors

Table 20. Allergan Major Business

Table 21. Allergan Overactive Bladder Medication Product and Services

Table 22. Allergan Overactive Bladder Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Global Overactive Bladder Medication Sales by Manufacturer (2019-2021e) & (K Units)

Table 24. Global Overactive Bladder Medication Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 25. Market Position of Manufacturers in Overactive Bladder Medication, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 26. Global Overactive Bladder Medication Production Capacity by Company, (K Units): 2020 VS 2021

Table 27. Head Office and Overactive Bladder Medication Production Site of Key Manufacturer

Table 28. Overactive Bladder Medication New Entrant and Capacity Expansion Plans

Table 29. Overactive Bladder Medication Mergers & Acquisitions in the Past Five Years

Table 30. Global Overactive Bladder Medication Sales by Region (2016-2021e) & (K Units)

Table 31. Global Overactive Bladder Medication Sales by Region (2021-2026) & (K Units)

Table 32. Global Overactive Bladder Medication Revenue by Region (2016-2021e) & (USD Million)

Table 33. Global Overactive Bladder Medication Revenue by Region (2021-2026) & (USD Million)

Table 34. Global Overactive Bladder Medication Sales by Type (2016-2021e) & (K Units)

Table 35. Global Overactive Bladder Medication Sales by Type (2021-2026) & (K Units)

Table 36. Global Overactive Bladder Medication Revenue by Type (2016-2021e) & (USD Million)

Table 37. Global Overactive Bladder Medication Revenue by Type (2021-2026) & (USD Million)

Table 38. Global Overactive Bladder Medication Price by Type (2016-2021e) & (USD/Unit)

Table 39. Global Overactive Bladder Medication Price by Type (2021-2026) & (USD/Unit)

Table 40. Global Overactive Bladder Medication Sales by Application (2016-2021e) & (K Units)

Table 41. Global Overactive Bladder Medication Sales by Application (2021-2026) & (K Units)

Table 42. Global Overactive Bladder Medication Revenue by Application (2016-2021e) & (USD Million)

Table 43. Global Overactive Bladder Medication Revenue by Application (2021-2026) & (USD Million)

Table 44. Global Overactive Bladder Medication Price by Application (2016-2021e) & (USD/Unit)

Table 45. Global Overactive Bladder Medication Price by Application (2021-2026) & (USD/Unit)

Table 46. North America Overactive Bladder Medication Sales by Country (2016-2021e) & (K Units)

Table 47. North America Overactive Bladder Medication Sales by Country (2021-2026) & (K Units)

Table 48. North America Overactive Bladder Medication Revenue by Country (2016-2021e) & (USD Million)

Table 49. North America Overactive Bladder Medication Revenue by Country (2021-2026) & (USD Million)

Table 50. North America Overactive Bladder Medication Sales by Type (2016-2021e) & (K Units)

Table 51. North America Overactive Bladder Medication Sales by Type (2021-2026) & (K Units)

Table 52. North America Overactive Bladder Medication Sales by Application (2016-2021e) & (K Units)

Table 53. North America Overactive Bladder Medication Sales by Application (2021-2026) & (K Units)

Table 54. Europe Overactive Bladder Medication Sales by Country (2016-2021e) & (K Units)

Table 55. Europe Overactive Bladder Medication Sales by Country (2021-2026) & (K Units)

Table 56. Europe Overactive Bladder Medication Revenue by Country (2016-2021e) & (USD Million)

Table 57. Europe Overactive Bladder Medication Revenue by Country (2021-2026) & (USD Million)

Table 58. Europe Overactive Bladder Medication Sales by Type (2016-2021e) & (K Units)

Table 59. Europe Overactive Bladder Medication Sales by Type (2021-2026) & (K Units)

Table 60. Europe Overactive Bladder Medication Sales by Application (2016-2021e) & (K Units)

Table 61. Europe Overactive Bladder Medication Sales by Application (2021-2026) & (K Units)

Table 62. Asia-Pacific Overactive Bladder Medication Sales by Region (2016-2021e) & (K Units)

Table 63. Asia-Pacific Overactive Bladder Medication Sales by Region (2021-2026) & (K Units)

Table 64. Asia-Pacific Overactive Bladder Medication Revenue by Region (2016-2021e) & (USD Million)

Table 65. Asia-Pacific Overactive Bladder Medication Revenue by Region (2021-2026) & (USD Million)

Table 66. Asia-Pacific Overactive Bladder Medication Sales by Type (2016-2021e) & (K Units)

Table 67. Asia-Pacific Overactive Bladder Medication Sales by Type (2021-2026) & (K Units)

Table 68. Asia-Pacific Overactive Bladder Medication Sales by Application (2016-2021e) & (K Units)

Table 69. Asia-Pacific Overactive Bladder Medication Sales by Application (2021-2026) & (K Units)

Table 70. South America Overactive Bladder Medication Sales by Country (2016-2021e) & (K Units)

Table 71. South America Overactive Bladder Medication Sales by Country (2021-2026) & (K Units)

Table 72. South America Overactive Bladder Medication Revenue by Country (2016-2021e) & (USD Million)

Table 73. South America Overactive Bladder Medication Revenue by Country (2021-2026) & (USD Million)

Table 74. South America Overactive Bladder Medication Sales by Type (2016-2021e) & (K Units)

Table 75. South America Overactive Bladder Medication Sales by Type (2021-2026) & (K Units)

Table 76. South America Overactive Bladder Medication Sales by Application (2016-2021e) & (K Units)

Table 77. South America Overactive Bladder Medication Sales by Application (2021-2026) & (K Units)

Table 78. Middle East & Africa Overactive Bladder Medication Sales by Country (2016-2021e) & (K Units)

Table 79. Middle East & Africa Overactive Bladder Medication Sales by Country (2021-2026) & (K Units)

Table 80. Middle East & Africa Overactive Bladder Medication Revenue by Country (2016-2021e) & (USD Million)

Table 81. Middle East & Africa Overactive Bladder Medication Revenue by Country (2021-2026) & (USD Million)

Table 82. Middle East & Africa Overactive Bladder Medication Sales by Type (2016-2021e) & (K Units)

Table 83. Middle East & Africa Overactive Bladder Medication Sales by Type (2021-2026) & (K Units)

Table 84. Middle East & Africa Overactive Bladder Medication Sales by Application (2016-2021e) & (K Units)

Table 85. Middle East & Africa Overactive Bladder Medication Sales by Application (2021-2026) & (K Units)

Table 86. Direct Channel Pros & Cons

Table 87. Indirect Channel Pros & Cons

Table 88. Overactive Bladder Medication Typical Distributors

Table 89. Overactive Bladder Medication Typical Customers

List of Figures

Figure 1. Overactive Bladder Medication Picture

Figure 2. Global Overactive Bladder Medication Sales Market Share by Type in 2020

Figure 3. Anticholinergics

Figure 4. Mirabegron

Figure 5. Botox

Figure 6. Global Overactive Bladder Medication Sales Market Share by Application in 2020

Figure 7. Idiopathic Overactive Bladder

Figure 8. Neurogenic Overactive Bladder

Figure 9. Global Overactive Bladder Medication Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Overactive Bladder Medication Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Overactive Bladder Medication Sales (2016-2026) & (K Units)

Figure 12. Global Overactive Bladder Medication Price by Type (2016-2026) & (USD/Unit)

Figure 13. Global Overactive Bladder Medication Production Capacity (2016-2026) & (K Units)

Figure 14. Global Overactive Bladder Medication Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Overactive Bladder Medication Market Drivers

Figure 16. Overactive Bladder Medication Market Restraints

Figure 17. Overactive Bladder Medication Market Trends

Figure 18. Global Overactive Bladder Medication Sales Market Share by Manufacturer in 2020

Figure 19. Global Overactive Bladder Medication Revenue Market Share by Manufacturer in 2020

Figure 20. Overactive Bladder Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Overactive Bladder Medication Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Overactive Bladder Medication Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Overactive Bladder Medication Sales Market Share by Region (2016-2026)

Figure 24. Global Overactive Bladder Medication Revenue Market Share by Region (2016-2026)

Figure 25. North America Overactive Bladder Medication Revenue (2016-2026) & (USD Million)

Figure 26. Europe Overactive Bladder Medication Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Overactive Bladder Medication Revenue (2016-2026) & (USD Million)

Figure 28. South America Overactive Bladder Medication Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Overactive Bladder Medication Revenue (2016-2026) & (USD Million)

Figure 30. Global Overactive Bladder Medication Sales Market Share by Type (2016-2026)

Figure 31. Global Overactive Bladder Medication Revenue Market Share by Type (2016-2026)

Figure 32. Global Overactive Bladder Medication Price by Type (2016-2026) & (USD/Unit)

Figure 33. Global Overactive Bladder Medication Sales Market Share by Application (2016-2026)

Figure 34. Global Overactive Bladder Medication Revenue Market Share by Application (2016-2026)

Figure 35. Global Overactive Bladder Medication Price by Application (2016-2026) & (USD/Unit)

Figure 36. North America Overactive Bladder Medication Sales Market Share by Type (2016-2026)

Figure 37. North America Overactive Bladder Medication Sales Market Share by Application (2016-2026)

Figure 38. North America Overactive Bladder Medication Sales Market Share by Country (2016-2026)

Figure 39. North America Overactive Bladder Medication Revenue Market Share by Country (2016-2026)

Figure 40. United States Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Overactive Bladder Medication Sales Market Share by Type (2016-2026)

Figure 44. Europe Overactive Bladder Medication Sales Market Share by Application (2016-2026)

Figure 45. Europe Overactive Bladder Medication Sales Market Share by Country (2016-2026)

Figure 46. Europe Overactive Bladder Medication Revenue Market Share by Country (2016-2026)

Figure 47. Germany Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Overactive Bladder Medication Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Overactive Bladder Medication Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Overactive Bladder Medication Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Overactive Bladder Medication Revenue Market Share by Region (2016-2026)

Figure 56. China Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Overactive Bladder Medication Sales Market Share by Type (2016-2026)

Figure 63. South America Overactive Bladder Medication Sales Market Share by Application (2016-2026)

Figure 64. South America Overactive Bladder Medication Sales Market Share by Country (2016-2026)

Figure 65. South America Overactive Bladder Medication Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Overactive Bladder Medication Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Overactive Bladder Medication Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Overactive Bladder Medication Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Overactive Bladder Medication Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Overactive Bladder Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source